Cat.#: ACPP-1327
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1494 | beta Catenin Blocking Peptide (AC1494) | 250 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1193 | Human M2 Protein (AC1193) | 5 µg | inquiry |
| ACPP-1794 | Human BAIAP2 Protein (AC1794) | 5 µg | inquiry |
| ACPP-1837 | Rat SCGN Protein (AC1837) | 2 µg | inquiry |
| ACPP-1545 | Human YWHAG Protein (AC1545) | 5 µg | inquiry |
| ACPP-1758 | Human GMFB Protein (AC1758) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.